03:24 AM EST, 02/18/2025 (MT Newswires) -- Stephen A Sherwin, Director, on February 13, 2025, sold 13,831 shares in Neurocrine Biosciences ( NBIX ) for $1,613,923. Following the Form 4 filing with the SEC, Sherwin has control over a total of 10,673 common shares of the company, with 10,673 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/914475/000091447525000071/xslF345X05/wk-form4_1739576962.xml ...

03:25 AM EST, 02/18/2025 (MT Newswires) -- Michael Cannon-Brookes, 10% Owner, Director, Chief Executive Officer, Co-Founder, on February 13, 2025, sold 7,948 shares in Atlassian ( TEAM ) for $2,516,542. Following the Form 4 filing with the SEC, Cannon-Brookes has control over a total of 246,388 Class A common shares of the company, with 246,388 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000156218025001215/xslF345X05/primarydocument.xml...

03:26 AM EST, 02/18/2025 (MT Newswires) -- Scott Farquhar, 10% Owner, Director, on February 13, 2025, sold 7,948 shares in Atlassian ( TEAM ) for $2,516,541. Following the Form 4 filing with the SEC, Farquhar has control over a total of 246,388 Class A common shares of the company, with 246,388 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000156218025001216/xslF345X05/primarydocument.xml ...

03:22 AM EST, 02/18/2025 (MT Newswires) -- Michael Mente, 10% Owner, Director, Co-Chief Executive Officer, on February 12, 2025, sold 201,761 shares in Revolve Group ( RVLV ) for $6,231,746. Following the Form 4 filing with the SEC, Mente has control over a total of 73,000 Class A common shares of the company, with 73,000 shares held directly. SEC Filing:...